RIGEL PHARMACEUTICALS INC short interest in 2025
In 2025, RIGEL PHARMACEUTICALS INC's disclosed short interest ran from 2.59% of shares outstanding on 15 Jan 2025 to 18.95% on 31 Dec 2025, a change of +16.36 percentage points. The year's high was 19.40% on 15 Oct 2025 and its low 2.59% on 15 Jan 2025, averaging 12.14% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 14.32 days on 31 Jul 2025. Full history: RIGEL PHARMACEUTICALS INC.
Cite this page
By year: 2018 · 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2025 in figures
- Start of year
- 2.59% (15 Jan 2025)
- End of year
- 18.95% (31 Dec 2025)
- Change
- +16.36 pp
- High
- 19.40% (15 Oct 2025)
- Low
- 2.59% (15 Jan 2025)
- Average
- 12.14%
- Highest days to cover
- 14.32 (31 Jul 2025)
- SEC filings marked
- 9
Every report in 2025
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 15 Jan 2025 | 2.59% | 1.99 | results (8-K) |
| 31 Jan 2025 | 3.18% | 2.69 | |
| 14 Feb 2025 | 7.65% | 4.31 | |
| 28 Feb 2025 | 8.39% | 8.10 | |
| 14 Mar 2025 | 8.90% | 5.98 | 10-K filed, results (8-K) |
| 31 Mar 2025 | 10.25% | 7.12 | |
| 15 Apr 2025 | 10.57% | 8.17 | |
| 30 Apr 2025 | 10.51% | 12.36 | |
| 15 May 2025 | 11.65% | 8.14 | 10-Q filed, results (8-K) |
| 30 May 2025 | 11.12% | 9.23 | |
| 13 Jun 2025 | 11.73% | 12.09 | |
| 30 Jun 2025 | 12.16% | 9.40 | |
| 15 Jul 2025 | 13.39% | 12.37 | |
| 31 Jul 2025 | 14.00% | 14.32 | |
| 15 Aug 2025 | 11.07% | 1.96 | 10-Q filed, results (8-K) |
| 29 Aug 2025 | 11.18% | 2.29 | |
| 15 Sep 2025 | 12.27% | 3.41 | |
| 30 Sep 2025 | 15.54% | 3.69 | |
| 15 Oct 2025 | 19.40% | 6.46 | |
| 31 Oct 2025 | 18.93% | 8.81 | |
| 14 Nov 2025 | 17.14% | 3.47 | 10-Q filed, results (8-K) |
| 28 Nov 2025 | 15.19% | 4.15 | |
| 15 Dec 2025 | 15.56% | 5.20 | |
| 31 Dec 2025 | 18.95% | 5.84 |
See also: RIGEL PHARMACEUTICALS INC's full history · most shorted US stocks of 2025 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.